OWINGS MILLS, Md., June 13, 2012 /PRNewswire/ -- Medifast Inc. (NYSE:MED), a leading United States manufacturer and provider of clinically proven, portion-controlled weight-loss products and programs, today announced a strategic partnership with Productos Medix S.A. de C.V. ("Medix"), a leader in pharmaceutical obesity products in Mexico. The agreement grants Medix an exclusive license for the distribution of Medifast meal replacement products and programs through physicians and Weight Control Centers in Mexico under the Medifast Brand. Medix plans to work with its extensive physician network while it also opens approximately 30 Weight Control Centers over the next two years.
"We're thrilled to partner with Medix as it allows Medifast to expand into international markets and opens new channels of distribution in the weight-loss industry," said Michael MacDonald, Chief Executive Officer and Executive Chairman of the Board at Medifast. "Medix is a terrific fit for the Medifast brand as we offer clients weight-loss choices and solutions to meet their lifestyle needs. Together, we can reduce the obesity epidemic in Mexico."" Mexico has the second largest obese population in the world and with this strategic partnership, Medifast and Medix will aim to help treat the obesity epidemic and provide solutions for people to live a healthier lifestyle," said Mario Lazcano Torres, Director of Corporate Affairs and Institutional Relations at Medix. "We believe we will be well positioned as this partnership enables a 360 degree approach to our obesity treatment programs and allows us to introduce a clinically proven, non-pharmaceutical meal replacement option for Mexican consumers." Medifast creates, produces and distributes products through several distribution channels. With this partnership, Medifast plans to expand its Medifast Weight Control Centers, which provide clinically-focused, one-on-one counseling to Center members, along with its network of physicians, which will offer the program to their patients. Medifast products and programs have been recommended by more than 20,000 doctors since 1980. Medifast provides clinically proven plans designed not only to help members lose weight, but to learn how to keep it off long term.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts